2/18/2021Junshi Bio Announces sNDA Acceptance for Toripalimab Combined with Ch...

2/18/20212020 Performance of Leading MNC Pharma Companies in China

2/17/2021U.S. Chamber Releases In-Depth Analysis of U.S.-China Economic Relatio...

2/17/2021CDE Issues the Technical Guidelines for Similarity Assessment and Indi...

2/12/2021Recent Executive Moves

2/10/2021CDE Issues Three Documents for Change Filings of Chemical Drugs and Bi...

2/9/2021NMPA Revises Packages Inserts of Thiamazole Formulations

2/9/2021NMPA Adds 72 Designated Core Laboratories to Support MedPharm Regulati...

2/9/2021Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for ...

2/9/2021Lee's Pharma Announces Breakthrough Therapy Designation of Sorrento's ...

2/9/2021Betta Pharma Mulls US$800M Hong Kong IPO in the First Half

2/9/2021NDA for Amarin's VASCEPA (icosapent ethyl) Accepted in China

2/9/2021Chance Pharma In-Licenses Drug-Device Combo AER-901 from Aerami Ther...

2/9/2021Drug Farm Closes $56M Financing to Advance Lead Hepatitis B Drug into ...

2/9/2021CDE Issues the Technical Guidelines for Clinical Trial of Human Immuno...

2/9/2021SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...

2/8/2021Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak

2/8/2021Bayer Receives Approval for Nubeqa in China for the Treatment of Men ...

2/8/2021Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...

2/8/2021BMS Granted Priority Review for NDA of Luspatercept in China

2/8/2021IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...

2/5/2021JBM Healthcare Debuts IPO on the Main Board of HKSE

2/5/2021CMS Acquires Dermatology Specialty Firm Luqa

2/5/2021NMPA Holds National Drug Registration and Post Marketing Regulation Co...

2/4/2021Local Drugmakers Dominated China's 4th Round of National VBP Again, As...

2/4/2021CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...

2/4/2021Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...

2/4/2021Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline

2/3/2021Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...

2/3/2021Amgen/Celgene's NDA for Apremilast Accepted in China

Page:102/362 Total number of articles:10841: [First][<<] [100] [101] [102] [103] [104] [>>] [End]